Francis GM, Montero CLB

Idioma: Español
Referencias bibliográficas: 18
Paginas: 207-211
Archivo PDF: 404.90 Kb.

RESUMEN

El Síndrome de Brugada en una entidad clínica que recientemente ha captado la atención de muchos clínicos. Se ha relacionado con un aumento en el riesgo de muerte cardiaca súbita y aparición de arritmias malignas especialmente en la población joven. El presente artículo contempla una revisión de los aspectos más importantes del síndrome.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Antzelevitch C: Brugada syndrome. Pacing Clin Electrophysiol 29:1130-1159, 2006

2. Antzelevitch C, Brugada P, Borggrefe M, et al: Brugada syndrome: report of the Second Consensus Conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 111:659-670, 2005

3. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol. 1992;20: 1391–1396

4. Benito B, Brugada R, Brugada J, Brugada P. Brugada Syndrome. Progress in Cardiovascular Diseases, Vol. 51, No. 1 (July/August), 2008: pp 1-22

5. Brugada J, Brugada R, Antzelevitch C, et al: Longterm follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and St segment elevation in precordial leads V1 to V3. Circulation 105:73-78, 2002

6. Belhassen B, Glick A, Viskin S: Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 110:1731-1737, 2004

7. Brugada R, Brugada J, Antzelevitch C, et al: Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 101:510-515, 2000

8. Brugada, P. Síndrome de Bugada. Vol. 12 Nº 3. Cardiovascular risk factors. 2003

9. Casini S, Tan HL, Bhuiyan ZA, et al: Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5linker in slow inactivation. Cardiovasc Res 76: 418-429, 2007

10. Di Diego JM, Cordeiro JM, Goodrow RJ, et al: Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation 106: 2004-2011, 2002

11. Eckardt L: Gender differences in Brugada syndrome. J Cardiovasc Electrophysiol 18:422-424, 2007

12. Matsuo K, AkahoshiM, Seto S, et al: Disappearance of the Brugada-type electrocardiogram after surgical castration: a role for testosterone and an explanation for the male preponderance. Pacing Clin Electrophysiol 26:1551-1553, 2003

13. Mok NS, Chan NY, Chiu AC: Successful use of quinidine in treatment of electrical storm in Brugada syndrome. Pacing Clin Electrophysiol 27:821-823, 2004 (6 Pt 1)

14. Priori SG, Napolitano C, Gasparini M, et al: Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 105:1342-1347, 2002

15. Probst V, Denjoy I, MeregalIi PG, et al: Clinical aspects and prognosis of Brugada syndrome in children. Circulation 115:2042-2048, 2007

16. Schulze-Bahr E, Eckardt L, Paul M, et al: Molecular genetics of the Brugada syndrome, in: Antzelevitch C, Brugada P (eds): The Brugada Syndrome: from Bench to Bedside (ed 1). Blackwell Publishing, 2005, p. 42-51

17. Yan GX, Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation. 1996;93:372–379.

18. Yan GX, Antzelevitch C: Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 100:1660-1666, 1999.